Bank of New York Mellon
ELGX

Bank of New York Mellon’s Endologix Inc ELGX Stock Holding History

Bank of New York Mellon’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-37,519
Closed -$248K – 4375
2019
Q1 		$248K Buy
37,519
+4,359
+13% +$28.7K ﹤0.01% 3812
2018
Q4 		$237K Sell
33,160
-2,659
-7% -$29.6K ﹤0.01% 3795
2018
Q3 		$684K Sell
35,819
-48
-0.1% -$1.71K ﹤0.01% 3481
2018
Q2 		$2.03M Sell
35,867
-581
-2% -$29.5K ﹤0.01% 2839
2018
Q1 		$1.54M Buy
36,448
+640
+2% +$27.5K ﹤0.01% 2962
2017
Q4 		$1.92M Buy
35,808
+128
+0.4% +$6.76K ﹤0.01% 2866
2017
Q3 		$1.59M Sell
35,680
-46,813
-57% -$2.13M ﹤0.01% 2961
2017
Q2 		$4.01M Sell
82,493
-1,502
-2% -$88.5K ﹤0.01% 2435
2017
Q1 		$6.08M Sell
83,995
-3,646
-4% -$241K ﹤0.01% 2232
2016
Q4 		$5.01M Buy
87,641
+11,451
+15% +$1.05M ﹤0.01% 2307
2016
Q3 		$9.75M Buy
76,190
+29,518
+63% +$3.78M ﹤0.01% 1895
2016
Q2 		$5.82M Buy
46,672
+13,367
+40% +$1.54M ﹤0.01% 2131
2016
Q1 		$2.78M Buy
33,305
+3,933
+13% +$324K ﹤0.01% 2468
2015
Q4 		$2.91M Sell
29,372
-125,309
-81% -$13.4M ﹤0.01% 2502
2015
Q3 		$19M Sell
154,681
-10,289
-6% -$1.4M 0.01% 1443
2015
Q2 		$25.3M Sell
164,970
-12,620
-7% -$2.08M 0.01% 1308
2015
Q1 		$30.3M Sell
177,590
-101,167
-36% -$15.3M 0.01% 1202
2014
Q4 		$42.6M Buy
278,757
+44,804
+19% +$5.59M 0.01% 981
2014
Q3 		$24.8M Buy
233,953
+36,885
+19% +$5.14M 0.01% 1294
2014
Q2 		$30M Buy
197,068
+53,653
+37% +$7.14M 0.01% 1213
2014
Q1 		$18.5M Buy
143,415
+111,975
+356% +$17.4M 0.01% 1519
2013
Q4 		$5.48M Buy
31,440
+990
+3% +$170K ﹤0.01% 2242
2013
Q3 		$4.91M Buy
30,450
+804
+3% +$127K ﹤0.01% 2261
2013
Q2 		$3.94M Buy
+29,646
New +$4.19M ﹤0.01% 2339

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Bank of New York Mellon's ELGX Position: Q2 2019 in Review

Bank of New York Mellon sold out of Endologix Inc (ELGX) in Q2 2019, closing a stake of 37,519 shares — an estimated $248K sold.

Bank of New York Mellon first reported a position in ELGX in Q2 2013 and held it in 24 quarters. The position peaked at $42.6M in Q4 2014. 75 funds tracked by Wall St. Rank hold ELGX as of Q2 2019.

  • Bank of New York Mellon reported no remaining Endologix Inc position as of Q2 2019 after selling out during the quarter.
  • Bank of New York Mellon sold 37,519 Endologix Inc shares in Q2 2019, an estimated $248K.
  • Bank of New York Mellon first reported a position in Endologix Inc in Q2 2013 and held it in 24 quarters.
  • Bank of New York Mellon's Endologix Inc position peaked at $42.6M in Q4 2014.
  • 75 funds tracked by Wall St. Rank held Endologix Inc as of Q2 2019.

Based on Bank of New York Mellon's 13F filing for Q2 2019, filed 12 Aug 2019.